These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16139000)

  • 1. Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy.
    Krebs I; Binder S; Stolba U; Glittenberg C; Brannath W; Goll A
    Am J Ophthalmol; 2005 Sep; 140(3):416-25. PubMed ID: 16139000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of photodynamic therapy for subfoveal choroidal neovascularization with pathologic myopia.
    Giansanti F; Virgili G; Donati MC; Giuntoli M; Pieretti G; Abbruzzese G; Menchini U
    Retina; 2012 Sep; 32(8):1547-52. PubMed ID: 22481476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment frequency and visual outcome in subfoveal choroidal neovascularization related to pathologic myopia treated with photodynamic therapy.
    Maár N; Ergun E; Luksch A; Stur M
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1262-6. PubMed ID: 16538450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
    Scupola A; Tiberti AC; Sasso P; Savastano MC; Mastrocola A; Marangoni D; Minnella AM; Falsini B; Balestrazzi E
    Retina; 2010 May; 30(5):739-47. PubMed ID: 20038860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
    Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
    Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term study of photodynamic therapy with verteporfin for choroidal neovascularization at the edge of chorioretinal atrophy in pathologic myopia.
    Pece A; Milani P; Isola V; Pierro L
    Ophthalmologica; 2011; 225(3):161-8. PubMed ID: 21212705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia.
    Virgili G; Varano M; Giacomelli G; Arena MC; Tedeschi M; Pascarella A; Catalano S; Menchini U
    Am J Ophthalmol; 2007 Jan; 143(1):77-82. PubMed ID: 17188043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
    Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
    Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy in highly myopic eyes with choroidal neovascularization: 5 years of follow-up.
    Coutinho AM; Silva RM; Nunes SG; Cachulo ML; Figueira JP; Murta JN
    Retina; 2011 Jun; 31(6):1089-94. PubMed ID: 21358463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia.
    Ergun E; Heinzl H; Stur M
    Am J Ophthalmol; 2004 Sep; 138(3):434-8. PubMed ID: 15364227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia: results from a randomized pilot study.
    Costa RA; Williams GA;
    Retina; 2006 Sep; 26(7):757-64. PubMed ID: 16963848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: a 12-month retrospective review.
    Costagliola C; Campa C; Incorvaia C; Parmeggiani F; Menzione M; Della Corte M; Rinaldi M; Romano M; Semeraro F
    Eur J Ophthalmol; 2008; 18(6):955-9. PubMed ID: 18988168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy.
    Hayashi K; Ohno-Matsui K; Teramukai S; Shimada N; Moriyama M; Hayashi W; Yoshida T; Tokoro T; Mochizuki M
    Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of photodynamic therapy in choroidal neovascularization due to pathologic myopia and related factors.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Int Ophthalmol; 2012 Apr; 32(2):119-25. PubMed ID: 22350116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two years follow-up outcome of verteporfin therapy for subfoveal choroidal neovascularization in pathologic myopia in Indian eyes.
    Hussain N; Khanna R; Das T; Narayanan R; Sunday OT; Bansal AG; Reddy R
    Indian J Ophthalmol; 2008; 56(6):465-8. PubMed ID: 18974516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reading ability and central visual field after photodynamic therapy.
    Krebs I; Binder S; Stolba U; Brunner S
    Ophthalmologica; 2004; 218(3):185-92. PubMed ID: 15103215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Pece A; Vadalà M; Isola V; Matranga D
    Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.